Heart Disease News and Research

Latest Heart Disease News and Research

GI nematode infections combat obesity and improve related metabolic disorders

Researchers at the University of Maryland School of Medicine, Baltimore, have shown in a mouse model that infection with nematodes (also known as roundworms) can not only combat obesity but ameliorate related metabolic disorders.

26 Apr 2013

Mayo Clinic implements electronic warning system to identify patients at risk of QT-related deaths

Using a one-of-a-kind computer-aided program, Mayo Clinic has developed and implemented a Mayo-wide electronic warning system to identify patients at risk of QT-related deaths from an abnormality in the heart's electrical system.

26 Apr 2013

Annual scientific symposium of the Cardiovascular Research Foundation celebrates its 25th anniversary

Media registration is now open online for TCT 2013 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation. Celebrating its 25th anniversary this year, the theme of TCT 2013 is envisioning the future, with a focus on innovation in medicine and technology.

26 Apr 2013

Combinations of sEH inhibition and PPARγ activation have beneficial effects on cardiometabolic syndrome

Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the pathological progression of cardiometabolic syndrome.

25 Apr 2013

Low-tech teaching techniques may improve training on pediatric CPR

New, low-tech teaching techniques used by novice instructors may improve training for healthcare providers in performing cardiopulmonary resuscitation (CPR) on children who suffer cardiac arrest.

25 Apr 2013

Cardiac risk patients treated with beta-blockers have lower rates of mortality

Patients at elevated cardiac risk who were treated with beta-blockers on the day of or following noncardiac, nonvascular surgery had significantly lower rates of 30-day mortality and cardiac illness, according to a study in the April 24 issue of JAMA.

25 Apr 2013

Beta blockade aids select surgery patients

Research supports the use of perioperative beta blockade in patients with cardiovascular risk factors undergoing nonvascular procedures, finding this treatment to significantly improve short-term survival.

25 Apr 2013

Schizophrenia patients misinterpret anger

A study shows that patients with schizophrenia struggle to recognize angry facial expressions, often mistaking them for fear.

25 Apr 2013

Serum C-peptide levels predict cardiovascular death risk

Levels of C-peptide predict the risk for death from cardiovascular disease in nondiabetic adults, show data from the US National Health and Nutrition Examination Survey.

25 Apr 2013

Schizophrenia cardiovascular risk under-recognized in primary care

UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than people without schizophrenia.

25 Apr 2013

Cardiovascular disease grave in patients with bipolar disorder

Cardiovascular disease has a particularly large impact on life expectancy if patients also have bipolar disorder, say researchers.

25 Apr 2013

Bipolar disorder questionnaires limited for patients with SUD

Researchers advise caution when using the Mood Disorder Questionnaire and the Hypomania Checklist-32 to diagnose bipolar disorder in patients treated for substance use disorders.

25 Apr 2013

Diagnostic hallmarks of POTS identified

US researchers have identified a constellation of symptoms that are associated with a diagnosis of postural tachycardia syndrome in adolescent patients with headache.

25 Apr 2013

Perosphere, Daiichi Sankyo sign clinical trial agreement

Perosphere Inc. and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that they have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse the anticoagulant activity of edoxaban, Daiichi Sankyo's investigational oral, once-daily, direct factor Xa-inhibitor.

25 Apr 2013

Transplant, MCS physicians examine value of hTEE management at symposium in Montreal

ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography management device, announced today that transplant and mechanical circulatory support physicians from around the world gathered in Montreal at an hTEE symposium to hear from heart failure experts about the value of hTEE management.

25 Apr 2013

Remembering workers and their families affected by workplace tragedy

Today is the International Day of Mourning, a day when we commemorate those workers and their families who have been affected by workplace tragedy—and strive to work together to ensure we all go home safely at the end of the day.

25 Apr 2013

Experts say there is more need for organ donation in Hispanic community

April is National Donate Life Month, held to encourage organ and tissue donation and to celebrate donors who give a new life to others. Organ donors are always in short supply. In the United States, more than 118,000 people are waiting for organ transplants, and 19 percent are Hispanic.

25 Apr 2013

XBiotech announces enrollment of first patient in Xilonix Phase III trial for treatment of cachexia

XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.

25 Apr 2013

Omega-3 polyunsaturated fatty acids associated with lower risk of heart failure mortality in adults

Omega-3 polyunsaturated fatty acids, namely DHA and EPA found in fatty fish, are associated with lower risk of heart failure mortality in adults with chronic heart failure or who have experienced a heart attack.

25 Apr 2013

Cook Medical initiates voluntary recall of Zilver PTX Drug Eluting Peripheral Stent

Based on its investigation into a small number of complaints that the delivery system of the device had separated at the tip of the inner catheter, Cook Medical has initiated a nationwide/global voluntary recall of its Zilver PTX Drug Eluting Peripheral Stent.

25 Apr 2013